P
Perceive Bio
Translating protective biology into powerful therapies
About Perceive Bio
Perceive Bio is a biotechnology startup based in South San Francisco, California. The company operates in the healthcare sector, specifically focusing on the development of novel therapeutics to prevent irreversible blindness. The company's primary focus is on retinal degeneration, a leading cause of blindness.
Perceive Bio's business model is centered around the translation of protective biology into powerful therapies. This involves the application of decades of academic research into two of the strongest protective biologies in retinal degeneration. The company's team, which boasts a successful track record in translating science through clinical development into strategic value, is currently preparing for clinical trials with lead programs in dry Age-Related Macular Degeneration (AMD) neuroprotection.
The company's revenue model is likely based on the development and commercialization of these novel therapeutics. Once the therapies have been clinically approved, they can be sold to healthcare providers and patients. The market for such therapies is significant, given the prevalence of retinal degeneration and the lack of effective treatments currently available.
In summary, Perceive Bio is a promising biotech startup that leverages academic research and clinical development to create innovative therapies for retinal degeneration. The company operates in a large and growing market, and its focus on novel protective biologies could position it well for future success.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 22
- Open positions
- None listed
- Dealroom signal
- 87.4/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
- Investment activity
- 1 company, latest Jan 2025
- Capital deployed
- $0
- Preferred round
- CORPORATE SPINOUT
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Jan 2023 | $78M | $312M | Deerfield · Catalio Capital Management · Retinal Degeneration Fund · Johnson & Johnson Innovation | ↗ |
| SPINOUTOther financing | Jan 2018 | — | — | Johns Hopkins University | — |
Growth signals
Latest recorded traffic for Perceive Bio is 1.3K monthly website visits, up 18.2% over the last three months. Perceive Bio's team grew 15.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Perceive Bio in the South San Francisco ecosystem
The Perceive Bio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Johnson & Johnson Innovation
Deerfield
Catalio Capital Management
Retinal Degeneration Fund
Braidwell
Series B and later1 investor entered at this stage
Perceive Biotherapeutics
Other known investors1 additional known investor
Johns Hopkins University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Perceive Bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Perceive Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









